Characterizing emerging companies in computational drug development.
Characterizing emerging companies in computational drug development.
复制标题
描述计算药物开发中新兴公司的特征。
DOI：
10.1038/s43588-024-00594-8
复制
发表时间：
2024
期刊：
影响因子：
--
通讯作者：
Reker,Daniel
中科院分区：
文献类型：
--
作者：
Markey,Chloe;Croset,Samuel;Woolley,OliviaRuth;Buldun,CanMartin;Koch,Christian;Koller,Daniel;Reker,Daniel
计算有望加速、降低风险并优化药物研发。越来越多的公司已经进入这一领域，专门从事新算法的设计，专有数据的计算和/或硬件的开发，以改善不同的药物管道阶段。这些公司的数量之多及其独特的战略和交易创造了一个高度复杂和竞争激烈的行业。我们全面分析该领域的公司，以突出趋势和机会，确定高度占用的风险领域和目前代表性不足的高价值利基。
Computation promises to accelerate, de-risk and optimize drug research and development. An increasing number of companies have entered this space, specializing in the design of new algorithms, computing on proprietary data, and/or development of hardware to improve distinct drug pipeline stages. The large number of such companies and their unique strategies and deals have created a highly complex and competitive industry. We comprehensively analyze the companies in this space to highlight trends and opportunities, identifying highly occupied areas of risk and currently underrepresented niches of high value.